A genome-scale metabolic model of a globally disseminated hyperinvasive M1 strain of Streptococcus pyogenes

Yujiro Hirose1,2, Daniel C Zielinski3, Saugat Poudel3

  • 1Department of Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.

Msystems
|August 19, 2024
PubMed

Insights

We created the first genome-scale metabolic model (GEM) for virulent Streptococcus pyogenes M1, named iYH543. This model accurately predicts gene essentiality and aids in understanding metabolism for new therapeutic targets.

Area of Science:

  • Microbiology and Systems Biology
  • Computational Biology and Metabolic Modeling

Background:

  • Streptococcus pyogenes causes significant human disease, with M1 serotype strains being particularly virulent.
  • Understanding S. pyogenes metabolism is crucial for developing effective therapeutic strategies against severe infections.
  • Genome-scale metabolic models (GEMs) are powerful tools for investigating bacterial metabolism and identifying drug targets.

Purpose of the Study:

  • To develop the first genome-scale metabolic model (GEM) for a serotype M1 Streptococcus pyogenes strain.
  • To validate the model's accuracy in predicting gene essentiality, auxotrophy, and growth phenotypes.
  • To provide a computational tool for understanding S. pyogenes metabolism and guiding drug discovery.

Main Methods:

  • Developed a GEM (iYH543) for S. pyogenes M1 by integrating draft models with experimental data.
  • Utilized transposon mutagenesis and growth screens for gene essentiality and autotrophy data.
  • Employed Biolog Phenotype microarrays to assess growth on various carbon sources for model refinement.

Main Results:

  • The iYH543 model achieved high accuracy: 92.6% for gene essentiality, 95% for amino acid auxotrophy, and 88% for carbon source utilization.
  • Model predictions identified discrepancies with experimental data, highlighting gaps in current knowledge of S. pyogenes metabolism.
  • The model successfully connected metabolic insights with virulence, offering hypotheses for future research.

Conclusions:

  • iYH543 is the first GEM for virulent S. pyogenes M1, offering novel insights into its metabolism.
  • The model serves as a valuable tool for rational drug design and computational screening against S. pyogenes.
  • iYH543 facilitates investigation into the interplay between metabolic pathways, virulence factor synthesis, and bacterial growth.